SCHEMBL21751333

SCHEMBL21751333

CC(C)(C)[Si](C)(C)Oc1cccc(-c2cn3c(=O)c(Cc4ccc(F)cc4)nc-3c(Cc3ccccc3)[nH]2)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 1/20 0.35
▸ TP53 P04637 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ NPC1 O15118 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ NR1H2 P55055 3/20 0.32
▸ NR1H3 Q13133 2/20 0.32
▸ KMT2A Q03164 3/20 0.31
▸ MEN1 O00255 2/20 0.31
▸ ADORA3 P0DMS8 1/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ HPGD P15428 1/20 0.31
▸ XBP1 P17861 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ PPARG P37231 1/20 0.30
▸ PPARA Q07869 1/20 0.30
▸ SMN1; SMN2 Q16637 2/20 0.30
▸ PTGDR2 Q9Y5Y4 1/20 0.30
▸ KDM4E B2RXH2 1/20 0.30
▸ CYP1A2 P05177 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21751381 0.95 MAOA (0.38) MAOANR1H2NR1H3KMT2AMEN1
SCHEMBL30514739 0.95 MAOA (0.38) MAOANR1H2NR1H3KMT2AMEN1
SCHEMBL30800205 0.92 SMN1; SMN2 (0.39) MAOATP53NPC1RAB9AKMT2A
SCHEMBL21751418 0.92 SMN1; SMN2 (0.39) MAOATP53NPC1RAB9AKMT2A
SCHEMBL21751456 0.91 ADORA2A (0.31) MAOAMAPTKMT2AMEN1ALDH1A1
SCHEMBL30800137 0.90 LTB4R (0.40) MAOAMAPTNPC1RAB9AKMT2A
SCHEMBL21751395 0.90 LTB4R (0.40) MAOAMAPTNPC1RAB9AKMT2A
SCHEMBL21751347 0.89 MAOA (0.34) MAOAKMT2AMEN1ALDH1A1HPGD
SCHEMBL21767317 0.89 MAOA (0.36) MAOARAB9AALDH1A1HPGDSMN1; SMN2
SCHEMBL21751400 0.88 MAOA (0.35) MAOATP53KMT2AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3981839-B1 COELENTERAZINE ANALOGS FOR USE IN LUCIFERASE-BASED ASSAYS PROMEGA CORP (US) 2025-08-20 — — EP disclosed
US-20240059697-A1 COELENTERAZINE ANALOGUES PROMEGA CORPORATION 2024-02-22 — — US disclosed
CN-112513188-B Coelenterazine analogs 普洛麦格公司 2024-01-26 — — CN disclosed
US-11691976-B2 Coelenterazine analogues PROMEGA CORPORATION (US) 2023-07-04 — — US disclosed
US-11691976-B2 Coelenterazine analogues PROMEGA CORPORATION (US) 2023-07-04 — — US disclosed
EP-3841173-A1 COELENTERAZINE ANALOGUES Promega Corporation (US) 2021-06-30 — — EP disclosed
US-20200062766-A1 COELENTERAZINE ANALOGUES PROMEGA CORPORATION 2020-02-27 — — US disclosed
WO-2020041579-A1 COELENTERAZINE ANALOGUES PROMEGA CORPORATION (US) 2020-02-27 — — WO disclosed
US-20200062766-A1 COELENTERAZINE ANALOGUES PROMEGA CORPORATION 2020-02-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200062766-A1 COELENTERAZINE ANALOGUES GLB1, SI, TCF7L2 MAOA 3004/4885TP53 3508/4885MAPT 4859/4885
US-11691976-B2 Coelenterazine analogues GLB1, SI, TCF7L2 MAOA 3004/4885TP53 3508/4885MAPT 4859/4885
US-20240059697-A1 COELENTERAZINE ANALOGUES GLB1, SI, TCF7L2 MAOA 3004/4885TP53 3508/4885MAPT 4859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback